Atlas Trials

Hodgkins Disease

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hodgkins Disease

RecordFirmDate
Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies (NCT02639559)Washington University School of Medicine2016-03-31
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention (NCT01951885)Case Comprehensive Cancer Center2014-07-07
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match (NCT01500161)Texas Oncology Cancer Center2011-11-01
Breast-Sparing Proton Therapy for Hodgkin's Disease (NCT02070393)Indiana University2011-09-01
Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant (NCT00901225)Duke University2009-05-01
Blood Samples to Evaluate Biomarkers of Donor Chimerism (NCT00764829)Fred Hutchinson Cancer Center2008-09-01
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer (NCT00754286)Albert Einstein College of Medicine2008-07-01
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant (NCT00697684)Beth Israel Deaconess Medical Center2008-06-01
Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors (NCT00713882)Weill Medical College of Cornell University2008-04-01
Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease (NCT00364676)Spectrum Pharmaceuticals, Inc2006-07-01
Autologous and Allogeneic Transplant for Relapsed Lymphoma (NCT00802113)Columbia University2003-06-01
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant (NCT00571662)University of Nebraska2000-12-08

Track Hodgkins Disease automatically

Every clearance here is in the API, with alerts when new ones post.